Top 10 Biotechnology VC Funds & Investors in Latvia (May 2026)

Portfolio highlights

• Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
• Soda Health — We are a healthcare technology company dedicated to eliminating health inequities through social determinants of health. Our services include supplemental benefit administration, highly customizable member benefit programs with restricted spending and multi-balance capabilities, and robust member data analytics with benefit design recommendations.
• Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Portfolio highlights

• Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
• Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
• Elmo — In our car sharing business Elmo Rent we wanted to serve maximum customers with minimum resources, so we created remote control technology to deliver vehicles.

Portfolio highlights

• Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
• Ascend Gene & Cell Therapies — Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
• Spruce Biosciences — Developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need

Portfolio highlights

• Edurio — Edurio is England's leading stakeholder feedback platform for schools and multi-academy trusts.
• Axial3D — Leading the way with the latest 3D imaging, models, and devices
• Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.

Portfolio highlights

• Angle Health — Digital-First Health Plans For The Modern Employee
• KURUKURU — Bring your comics and visual stories to life in clicks on KURUKURU.
• Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.

Portfolio highlights

• DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
• NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
• Bonum Therapeutics — Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.

Portfolio highlights

• eAgronom — eAgronom helps farmers generate additional revenue streams, improve soil quality, and access better financing.
• KOOL Latvija — "KOOL Latvija" is a new concept gas station created in Latvia, which at the same time is also a convenient fast shopping place.
• Bioreactors.net — Biotechnical center is an innovative company and we provide solutions for industrial biotechnology processes, bioreactor manufacturing and industrial automation. We manufacture bioreactors for laboratory, pilot and industrial scale.

Portfolio highlights

• OYO — OYO Hotels in UK - Find the best last minute hotel deals with OYO hotels in UK. Book Budget hotels in London, Edinburgh, Manchester, Liverpool, Bristol with upto 50% off, Free cancellation, free WiFi & Breakfast.
• Quant — Quant is a premier quantitative research and investment fund led by engineering, mathematics, and business students at the University of Illinois Urbana-Champaign. We employ state-of-the-art analysis tools like deep learning and natural language processing to gain an edge on financial markets across the globe.
• Yellowbrick Data — Yellowbrick Data Warehouse: the only modern enterprise cloud data warehouse. Run complex queries on data dispersed across the enterprise, cloud, on-prem & edge.

Portfolio highlights

• Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
• Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
• Arialys Therapeutics — Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.

Portfolio highlights

• Avalyn Pharma — This does NOT display on the home page
• Mariana Oncology — Mariana Oncology is a biotechnology research industry.
• VistaGen Therapeutics — VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the central nervous system (CNS). VistaGen's lead product candidate, AV-101, is a next generation, orally available prodrug candidate in Phase 2development, initially for the adjunctive treatment of Major Depressive Disorder (MDD) in patients with an inadequate response to standard antidepressants.